• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

腺病毒8型与9型交叉反应的免疫学基础

Immunological basis of the adenovirus 8-9 cross-reaction.

作者信息

Hierholzer J C, Dowdle W R

出版信息

J Virol. 1970 Dec;6(6):782-7. doi: 10.1128/JVI.6.6.782-787.1970.

DOI:10.1128/JVI.6.6.782-787.1970
PMID:4992997
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC376195/
Abstract

The dedecon and hexon components of adenovirus types 8 and 9 have been extensively purified for use in establishing the basis of the cross-reaction between these types. Dodecons, the complete hemagglutinins, were purified 304- to 362-fold by fluorocarbon extraction, calcium phosphate batch chromatography, and ion-exchange column chromatography. Hexons, the group complement-fixation (CF) antigens, were purified 230- to 240-fold by erythrocyte adsorption, ion-exchange chromatography, and exclusion chromatography. Component antisera prepared in rabbits were tested in reciprocal fashion with crude virus and dodecon and hexon components. By hemagglutination-inhibition (HI), the dodecons of types 8 and 9 demonstrated the same predominantly one-sided relationship characteristic of the crude antigens. Some neutralizing activity was associated with both dodecons and hexons of each type. However, combining anti-dodecon and anti-hexon sera or producing antisera against the combined dodecon-hexon components resulted in neutralizing titers which were identical to titers obtained with antisera against the crude virus harvests. Dedecons of each type appear to share at least one antigenic determinant with hexons of the same type, and this determinant may reside on the vertex capsomere. Hexons possess group- and type-specific determinants, as shown by CF, neutralization, and immunodiffusion tests, and may exhibit some minor relationship between types 8 and 9. The results with the purified components are consistent with the predominantly one-sided antigenic relationship between types 8 and 9 in the conventional HI tests and the largely type-specific relationship by neutralization tests.

摘要

已对8型和9型腺病毒的十二聚体和六邻体成分进行了广泛纯化,用于确定这些类型之间交叉反应的基础。作为完整血凝素的十二聚体,通过氟碳萃取、磷酸钙分批层析和离子交换柱层析纯化了304至362倍。作为组补体结合(CF)抗原的六邻体,通过红细胞吸附、离子交换层析和排阻层析纯化了230至240倍。用兔制备的成分抗血清与粗病毒以及十二聚体和六邻体成分进行双向检测。通过血凝抑制(HI)试验,8型和9型的十二聚体表现出与粗抗原相同的主要为单侧关系的特征。每种类型的十二聚体和六邻体都具有一些中和活性。然而,将抗十二聚体血清和抗六邻体血清混合,或制备针对十二聚体 - 六邻体组合成分的抗血清,所产生的中和效价与用针对粗病毒收获物的抗血清所获得的效价相同。每种类型的十二聚体似乎与同类型的六邻体至少共享一个抗原决定簇,并且这个决定簇可能位于顶点衣壳粒上。如CF、中和及免疫扩散试验所示,六邻体具有组特异性和型特异性决定簇,并且在8型和9型之间可能表现出一些微小的关系。纯化成分的检测结果与传统HI试验中8型和9型之间主要为单侧抗原关系以及中和试验中很大程度上为型特异性关系是一致的。

相似文献

1
Immunological basis of the adenovirus 8-9 cross-reaction.腺病毒8型与9型交叉反应的免疫学基础
J Virol. 1970 Dec;6(6):782-7. doi: 10.1128/JVI.6.6.782-787.1970.
2
Comparative studies on the soluble components of adenovirus types 9 and 15 and the intermediate strain 9-15.9型和15型腺病毒以及中间株9-15可溶性成分的比较研究。
J Virol. 1968 Oct;2(10):1200-10. doi: 10.1128/JVI.2.10.1200-1210.1968.
3
Comparative studies of adenovirus hexon antigens.腺病毒六邻体抗原的比较研究。
Arch Gesamte Virusforsch. 1972;36(1):80-92. doi: 10.1007/BF01250298.
4
Production and evaluation of a purified adenovirus group-specific (hexon) antigen for use in the diagnostic complement fixation test.用于诊断补体结合试验的纯化腺病毒群特异性(六邻体)抗原的制备与评估。
Appl Microbiol. 1971 Apr;21(4):718-22. doi: 10.1128/am.21.4.718-722.1971.
5
Biophysical comparison of two canine adenoviruses.两种犬腺病毒的生物物理比较
J Virol. 1970 Apr;5(4):507-12. doi: 10.1128/JVI.5.4.507-512.1970.
6
Mosaics of capsid components produced by cocultivation of certain human adenoviruses in vitro.通过某些人类腺病毒体外共培养产生的衣壳成分镶嵌体。
Virology. 1971 May;44(2):383-95. doi: 10.1016/0042-6822(71)90269-8.
7
Separation and characterization of soluble adenovirus type 9 components.9型可溶性腺病毒成分的分离与鉴定
J Virol. 1967 Dec;1(6):1101-8. doi: 10.1128/JVI.1.6.1101-1108.1967.
8
Purification of adenovirus 4 type-specific hemagglutinins for use in diagnostic counterelectrophoresis tests.用于诊断对流免疫电泳试验的4型腺病毒特异性血凝素的纯化
J Med Virol. 1979;4(4):279-90. doi: 10.1002/jmv.1890040406.
9
The proteins of adenovirus type 5.5型腺病毒的蛋白质
Arch Gesamte Virusforsch. 1970;29(1):1-24. doi: 10.1007/BF01253875.
10
Counterimmunoelectrophoresis with adenovirus type-specific anti-hemagglutinin sera as a rapid diagnostic method.以腺病毒型特异性抗血凝素血清进行对流免疫电泳作为一种快速诊断方法。
J Immunol. 1974 Mar;112(3):987-95.

引用本文的文献

1
Serological and genetic characterisation of a unique strain of adenovirus involved in an outbreak of epidemic keratoconjunctivitis.一起流行性角结膜炎暴发中涉及的一株独特腺病毒的血清学和遗传学特征分析
J Clin Pathol. 2004 Apr;57(4):411-6. doi: 10.1136/jcp.2003.012500.
2
Molecular characterization of the type-specific gamma-determinant located on the adenovirus fiber.位于腺病毒纤维上的型特异性γ决定簇的分子特征
J Virol. 1997 Sep;71(9):6576-81. doi: 10.1128/JVI.71.9.6576-6581.1997.
3
Application of a solid-phase immunofluorometric assay to the selection of monoclonal antibody specific for the adenovirus group-reactive hexon antigen.固相免疫荧光测定法在选择针对腺病毒群反应性六邻体抗原的单克隆抗体中的应用。
Arch Virol. 1984;80(1):1-10. doi: 10.1007/BF01315289.
4
Antigenically intermediate human adenovirus strain associated with conjunctivitis.与结膜炎相关的抗原性中间型人腺病毒株
J Clin Microbiol. 1981 Feb;13(2):395-7. doi: 10.1128/jcm.13.2.395-397.1981.
5
The immune response to virus infections.对病毒感染的免疫反应。
Vet Immunol Immunopathol. 1983 Mar;4(1-2):237-77. doi: 10.1016/0165-2427(83)90059-4.
6
Immunological relationship among human adenoviruses of subgenus D.D亚属人类腺病毒之间的免疫关系
Arch Virol. 1982;72(3):199-209. doi: 10.1007/BF01348965.
7
Monoclonal antibodies to the glycoprotein of vesicular stomatitis virus: comparative neutralizing activity.针对水疱性口炎病毒糖蛋白的单克隆抗体:比较中和活性。
J Virol. 1982 Apr;42(1):220-7. doi: 10.1128/JVI.42.1.220-227.1982.
8
Neutralization of adenovirus toxins: specificity and antigenic relationships.腺病毒毒素的中和作用:特异性与抗原关系
Med Microbiol Immunol. 1972;157(4):325-34. doi: 10.1007/BF02121124.
9
Comparison of immunization methods for producing reference adenovirus antisera in horses.马体内产生腺病毒参考抗血清的免疫方法比较
Appl Microbiol. 1972 Sep;24(3):398-404. doi: 10.1128/am.24.3.398-404.1972.
10
Production and evaluation of a purified adenovirus group-specific (hexon) antigen for use in the diagnostic complement fixation test.用于诊断补体结合试验的纯化腺病毒群特异性(六邻体)抗原的制备与评估。
Appl Microbiol. 1971 Apr;21(4):718-22. doi: 10.1128/am.21.4.718-722.1971.

本文引用的文献

1
Protein measurement with the Folin phenol reagent.使用福林酚试剂进行蛋白质测定。
J Biol Chem. 1951 Nov;193(1):265-75.
2
PRODUCTION AND STANDARDIZATION OF ADENOVIRUS TYPES 1 TO 18 REFERENCE ANTISERA.1至18型腺病毒参考抗血清的制备与标准化
Am J Hyg. 1964 May;79:310-9. doi: 10.1093/oxfordjournals.aje.a120385.
3
PRODUCTION OF SPECIFIC NEUTRALIZING ANTIBODY WITH SOLUBLE ANTIGENS OF TYPE 5 ADENOVIRUS.用5型腺病毒可溶性抗原产生特异性中和抗体
Proc Soc Exp Biol Med. 1963 Oct;114:37-42. doi: 10.3181/00379727-114-28579.
4
Chromatography of adenoviruses on calcium phosphate columns.腺病毒在磷酸钙柱上的色谱分析。
Acta Virol. 1962 Jul;6:302-8.
5
A new and rapid method for isolating viruses by selective fluorocarbon deproteinization.一种通过选择性氟碳脱蛋白来分离病毒的全新快速方法。
Trans N Y Acad Sci. 1956 Jun;18(8):701-3. doi: 10.1111/j.2164-0947.1956.tb00497.x.
6
The structure of group II adenoviruses.II 型腺病毒的结构
J Gen Virol. 1967 Oct;1(4):553-60. doi: 10.1099/0022-1317-1-4-553.
7
Standardization and certification of reference antigens and antisera for 30 human adenovirus serotypes.30种人腺病毒血清型参考抗原和抗血清的标准化与认证
Am J Epidemiol. 1967 Nov;86(3):617-33. doi: 10.1093/oxfordjournals.aje.a120771.
8
[Type-specific antigens of adenovirus].[腺病毒的型特异性抗原]
Arch Gesamte Virusforsch. 1969;26(4):355-65.
9
Comparative studies on the soluble components of adenovirus types 9 and 15 and the intermediate strain 9-15.9型和15型腺病毒以及中间株9-15可溶性成分的比较研究。
J Virol. 1968 Oct;2(10):1200-10. doi: 10.1128/JVI.2.10.1200-1210.1968.
10
The serological relationship of the soluble antigens of adenovirus type 19.19型腺病毒可溶性抗原的血清学关系
J Gen Virol. 1968 May;2(3):331-40. doi: 10.1099/0022-1317-2-3-331.